Skip to main content

UBS Group AG

Position in NXL — Nexalin Technology, Inc.

CIK 1610520 ZURICH, V8

Position in NXL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,851
+$8,594 QoQ
Shares Held
894
+20.8% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 20 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 63% Shared 0% None 37%

Common Shares in NXL Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,667,499,887 across 137 Medical Devices names. NXL ranks #122 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NXL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,851 26,825
2026-03-31 $257 22,189
2025-12-31 $294 15,901
2025-09-30 $13 440
2025-06-30 $496 15,085
2024-12-31 $12 140
2024-09-30 $54 2,466
2024-06-30 $227 4,036
2024-03-31 $194 4,168
2023-06-30 $59 2,000
2023-03-31 $84 3,158
2022-12-31 $109 4,401
2022-09-30 $149 4,143